6
I P T F O R P T S D
researchers compared group IPT to a waiting list (admittedly
not the strongest
comparison condition) in which patients were repeatedly evaluated but did not
receive psychotherapy. Medication was held stable for those who were taking
psychotropic medication.
Paired woman therapists conducted 16 two- hour IPT sessions for groups
of three to five women. The women in treatment had been multiply trauma-
tized, with an average of 6.8 (standard deviation [SD] = 4.2) interpersonal
traumas (!). The authors considered the dropout
rate low in the context of
this high- risk, non– treatment- seeking population: 71% of patients attended at
least half the sessions. On the other hand, only 63% of IPT and 44% of waiting
list subjects completed symptom ratings at treatment termination, and only
81% of IPT patients and 63% of waiting list subjects were rated at four- month
follow- up.
Scores on the Clinician- Administered PTSD Scale (CAPS; Blake et al.,
1995; Weathers et al., 2001) fell from 65.2 (SD = 20.9) in IPT to 40.6 post
treatment and 38.5 (SD = 24.4) at four month follow- up: that is,
from severe
symptoms to mild to moderate symptoms. The waiting list subject scores
were 62.6 (SD = 16.6), 56.6 (25.1), and 41.6 (SD = 26.7) at the three time points
(
p <
.001). IPT also produced significantly greater reductions on the Hamilton
Depression Rating Scale (Hamilton, 1960) than did waiting list status. IPT pa-
tients improved on four of five subscales (all but Aggression) of the Inventory
of Interpersonal Problems (IIP; Horowitz et al., 1988),
whereas waiting list
group IIP scores worsened over time.
Summary:
The Krupnick study is important as the first randomized con-
trolled trial of IPT for PTSD, and it generated interesting results. A score
greater than 60 on the CAPS, where the patients started before treatment,
indicates
severe PTSD; a score of 40 falls right on the diagnostic threshold
(Weathers et al., 2001). Thus group IPT tended not to bring about remission,
but did produce clinically meaningful improvement in a repeatedly battered
population. A weakness of the study is the waiting list control condition: a
comparison is only as strong as its comparator, and showing that IPT was
better than no treatment is not definitively impressive.
Nonetheless, it’s a start,
a step into new comparative treatment territory. Although the five therapists
in this study had some clinical experience, ranging from five to twenty years of
work in group and psychodynamic psychotherapy, only one of them had had
prior experience with IPT. If the therapists were not polished in delivering IPT,
the results might then underestimate the potency of the treatment.
Do'stlaringiz bilan baham: